Showing results (2591-2600 of 3,795) with videos related to

Sort By:
Pageof 380
Archives of Physical Medicine and Rehabilitation|February 1, 2011
Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trialMark S Nash, John E Lewis, Trevor A Dyson-Hudson, et al.
Head & Neck|November 1, 2002
Merkel cell carcinoma of the head and neck: a retrospective case seriesAnthony E Brissett, Kerry D Olsen, Jan L Kasperbauer, et al.
Journal of General Internal Medicine|October 10, 2019
Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA StudyErin R Cleveland, Hongyan Ning, Miriam B Vos, et al.
Cancer Treatment and Research Communications|May 26, 2019
Relationship between serum markers and volume of liver metastases in castration-resistant prostate cancerLahiru Ranasinghe, Patrick Cotogno, Elisa Ledet, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2022
PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndromeNatasha E Lewis, Qi Gao, Kseniya Petrova-Drus, et al.
Plos Genetics|April 26, 2019
Anteroposterior patterning of the zebrafish ear through Fgf- and Hh-dependent regulation of hmx3a expressionRyan D Hartwell, Samantha J England, Nicholas A M Monk, et al.
Placenta|August 21, 2009
Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsiaA F Orozco, C J Jorgez, W D Ramos-Perez, et al.
Annals of the Rheumatic Diseases|June 8, 2010
Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohortAngelo L Gaffo, Jeffrey M Roseman, David R Jacobs, et al.
Diabetologia|April 29, 2020
Selective stimulation of colonic L cells improves metabolic outcomes in miceJo E Lewis, Emily L Miedzybrodzka, Rachel E Foreman, et al.
Antiviral Chemistry & Chemotherapy|August 3, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimensM E Lewis, P Simpson, J Mori, et al.
Pageof 380